| http://www.w3.org/ns/prov#value | - It plans to use proceeds to repay debt, fund the development of its chronic-pain drug Zohydro and ongoing commercialization of its Sumavel DosePro needle-free delivery system, as well as for working capital and other general corporate purposes.
|
